These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2576516)

  • 1. [Interaction of rilmenidine with renal imidazoline-guanidine sites].
    Lachaud V; Bidet M; Coupry I; Podevin RA; Poujeol P; Parini A
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():15-8. PubMed ID: 2576516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selectivity of alpha 2-adrenergic agonists for the imidazoline-guanidine and alpha 2-adrenergic receptors].
    Lachaud V; Coupry I; Podevin RA; Koenig E; Parini A
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1135-7. PubMed ID: 2573323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different affinities of alpha 2-agonists for imidazoline and alpha 2-adrenergic receptors.
    Coupry I; Lachaud V; Podevin RA; Koenig E; Parini A
    Am J Hypertens; 1989 Jun; 2(6 Pt 1):468-70. PubMed ID: 2569318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imidazoline-guanidinium and alpha 2-adrenergic binding sites in basolateral membranes from human kidney.
    Lachaud-Pettiti V; Podevin RA; Chrétien Y; Parini A
    Eur J Pharmacol; 1991 Jan; 206(1):23-31. PubMed ID: 1648494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of imidazoline-guanidinium receptive sites in renal medulla from human kidney.
    Lachaud V; Limon I; Tesson F; Coupry I; Parini A
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):69S-71S. PubMed ID: 1350730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of nonadrenergic [3H]rilmenidine binding in rat brain and kidney.
    King PR; Suzuki S; Louis WJ; Gundlach AL
    Ann N Y Acad Sci; 1995 Jul; 763():194-207. PubMed ID: 7677331
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of binding sites for [3H]-idazoxan, [3H]-P-aminoclonidine and [3H]-rauwolscine in the kidney of the dog.
    Evans RG; Haynes JM
    Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):649-58. PubMed ID: 7813124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of imidazolines on Na+ transport and intracellular pH in renal proximal tubule cells.
    Bidet M; Poujeol P; Parini A
    Biochim Biophys Acta; 1990 May; 1024(1):173-8. PubMed ID: 2337612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors.
    Evans RG; Anderson WP
    Br J Pharmacol; 1995 Sep; 116(1):1557-70. PubMed ID: 8564219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an imidazoline/guanidinium receptive site distinct from the alpha 2-adrenergic receptor.
    Parini A; Coupry I; Graham RM; Uzielli I; Atlas D; Lanier SM
    J Biol Chem; 1989 Jul; 264(20):11874-8. PubMed ID: 2545687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of imidazoline sites in rabbit kidney.
    Hamilton CA; Jardine E; Reid JL
    Eur J Pharmacol; 1993 Oct; 243(1):95-7. PubMed ID: 7902815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive features of rilmenidine possibly related to its selectivity for imidazoline receptors.
    Harron DW
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):91S-98S. PubMed ID: 1350732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of clonidine and rilmenidine with imidazoline-preferring receptors.
    Lachaud V; Coupry I; Podevin RA; Dausse JP; Koenig E; Parini A
    J Hypertens Suppl; 1988 Dec; 6(4):S511-3. PubMed ID: 3241245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of imidazoline-preferring receptors in regulation of sympathetic tone.
    Sannajust F; Head GA
    Am J Cardiol; 1994 Dec; 74(13):7A-19A. PubMed ID: 7998588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selectivity of a new antihypertensive agent, rilmenidine, for imidazoline receptors in the human brain].
    Bricca G; Dontenwill M; Feldman J; Belcourt A; Bousquet P
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1325-8. PubMed ID: 1979731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.
    Chan CK; Burke SL; Head GA
    J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA
    Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney.
    King PR; Suzuki S; Hosseini AR; Iakovidis D; Nero TL; Jackman GP; Louis WJ; Gundlach AL
    J Auton Nerv Syst; 1998 Oct; 72(2-3):118-28. PubMed ID: 9851560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.